Cargando…
Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients
Several therapeutic regimens for COVID-19 have been studied, such as combination antiviral therapies. We aimed to compare outcome of two types of combination therapies atazanavir/ritonavir (ATV/r) or lopinavir/ritonavir (LPV/r) plus hydroxychloroquine among COVID-19 patients. 108 patients with moder...
Autores principales: | Mazaherpour, Hossein, Sofian, Masoomeh, Farahani, Elham, Abdi, Alireza, Mazaherpour, Sakine, Bavand, Anahita, Ramezani, Amitis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742149/ https://www.ncbi.nlm.nih.gov/pubmed/35013710 http://dx.doi.org/10.1155/2022/1522426 |
Ejemplares similares
-
Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients
por: Mazaherpour, Hossein, et al.
Publicado: (2021) -
Evaluating the Factors Affecting COVID-19 Patients' Mortality in Arak in 2020
por: Mazaherpour, Hossein, et al.
Publicado: (2022) -
SARS-CoV-2 Viral Shedding and Associated Factors among COVID-19 Inpatients and Outpatients
por: Sofian, Masoomeh, et al.
Publicado: (2022) -
Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women
por: Ramezani, Amitis, et al.
Publicado: (2019) -
A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population
por: Ashrafian, Fatemeh, et al.
Publicado: (2023)